← Back to Search

Wellinks for Chronic Obstructive Pulmonary Disease (ASPIRE Trial)

N/A
Waitlist Available
Research Sponsored by Convexity Scientific Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

ASPIRE Trial Summary

This trial will test whether the Wellinks COPD Solution can improve quality of life, reduce healthcare resource utilization, and improve pulmonary function for patients with COPD.

Eligible Conditions
  • Chronic Obstructive Pulmonary Disease

ASPIRE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
COPD Self-Efficacy Scale
COPD Symptoms Assessment
Modified Medical Research Council Dyspnea Scale (mMRC)
+1 more
Other outcome measures
Participant Net Promoter Score (nPS)

ASPIRE Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm 2Experimental Treatment1 Intervention
Arm 1: Subjects will receive 24 weeks of access to the Wellinks Solution. The latter 12 weeks will be entirely asynchronous.
Group II: Arm 1Experimental Treatment1 Intervention
Arm 1: Subjects will receive 24 weeks of access to the Wellinks Solution.

Find a Location

Who is running the clinical trial?

Convexity Scientific IncLead Sponsor
1 Previous Clinical Trials
150 Total Patients Enrolled
COPD FoundationOTHER
17 Previous Clinical Trials
238,161 Total Patients Enrolled
Gretchen McCrearyStudy DirectorCOPD Foundation

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Florida
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0
Recent research and studies
clinicaltrials.govStudy
Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD
2022. "Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05259280.
~47 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top